Lost Money on Stride, Inc. (LRN)? Contact Levi & Korsinsky to Protect Your Rights

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Stride, Inc. ("Stride, Inc.") (NYSE:LRN) concerning possible violations of federal securities laws. On October 28, 2025, Stride reported its first quarter fiscal 2026 earnings after market. While earnings beat expectations, enrollment numbers […]

ATYR ALERT: Securities Fraud Class Action Launched Against aTyr Pharma, Inc. – December 8, 2025 Deadline

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / If you suffered a loss on your aTyr Pharma, Inc. (NASDAQ:ATYR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/atyr-pharma-inc-lawsuit-submission-form?prid=176262&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savers Value Village, Inc. – SVV

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Savers Value Village, Inc. ("Savers" or the "Company") (NYSE:SVV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Savers and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savers Value Village, Inc. – SVV

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Savers Value Village, Inc. ("Savers" or the "Company") (NYSE:SVV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Savers and certain of its officers and/or

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

(NASDAQ:ZION),(NasdaqGM:ZIONP), NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP) resulting from allegations that Zions Bancorporation may have issued materially misleading business information to the investing public. SO WHAT:

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 09, 2025 NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities

Levi & Korsinsky Urges Cytokinetics (CYTK) Shareholders to Act Before Lead Plaintiff Deadline November 17, 2025

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=176288&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

November 18, 2025 Deadline: Join Class Action Lawsuit Against KBR, Inc. (KBR) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / November 9, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=176287&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Marriott International Provides Financial Outlook Update Following Termination of Agreement with Sonder

Marriott International, Inc. (NASDAQ: MAR) announced today that its licensing agreement with Sonder Holdings Inc. (NASDAQ: SOND, “Sonder”) was no longer in effect due to Sonder's default. With the removal of the Sonder rooms from Marriott's system, Marriott's net rooms growth for 2025 is now expected to approach 4.5 percent. There are no changes to

Scroll to Top